期刊文献+

盐酸法舒地尔注射液影响因素试验及其光降解产物的液相色谱-质谱分析 被引量:1

Influential Factors for Quality of Fasudil Hydrochloride Injection and Liquid Chromatography-Mass Spectrometry Analysis of Its Photodegradation Product
下载PDF
导出
摘要 目的考察盐酸法舒地尔注射液的影响因素并鉴定其光降解产物。方法对盐酸法舒地尔注射液进行高温、光照处理,并用液相色谱-质谱联用技术鉴定其光降解产物。结果盐酸法舒地尔注射液高温条件下稳定,光照条件下产生一光降解杂质异喹啉-5-磺酸。结论盐酸法舒地尔注射液在高温条件下稳定,在光照条件下不稳定,应避光保存,光降解杂质为异喹啉-5-磺酸。 Objective To investigate the influencing factors for the quality of Fasudil Hydrochloride Injection and identify its photodegradation product. Methods Fasudil Hydrochloride Injection was put at high temperature and under illumination. The photodegradation product of Fasudil Hydrochloride Injection was identified by liquid chro- matography mass spectrometry. Results Fasudil Hydrochloride Injection was stable at high temperature, but pro- duced isoquinoline-5-sulfonic acid as an impurity under illumination. Conclusion Fasudil Hydrochloride Injection is stable at high temperature, but it is unstable under illumination, with isoquinoline-5-sulfonic acid as a photodegra- dation product. Fasudil Hydrochloride Injection should be kept in the dark.
出处 《安徽中医学院学报》 CAS 2013年第2期83-86,共4页 Journal of Anhui Traditional Chinese Medical College
关键词 盐酸法舒地尔注射液 影响因素 降解产物 液相色谱-质谱 Fasudil Hydrochloride Injection influencing factor photodegradation product liquid chromatography-mass spectrometry
  • 相关文献

参考文献5

二级参考文献90

  • 1周海钧.药品注册的国际技术要求(质量部分) 第1版[M].北京:人民卫生出版社,2000..
  • 2Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 3Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 4Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 5Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 6O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 7Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 8Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 9Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 10Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.

共引文献2157

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部